{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:54Z","timestamp":1792789854804,"version":"4.5.0"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507805"],"award-info":[{"award-number":["2023YFC2507805"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350103"],"award-info":[{"award-number":["82350103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425003"],"award-info":[{"award-number":["82425003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Chimeric antigen receptor T\u2010cell (CAR\u2010T) therapy has shown transformative potential in treating malignant tumours, with increasing global approval of CAR\u2010T products. However, high\u2010production costs and risks associated with viral vector\u2010based CAR\u2010T cells\u2014such as insertional mutagenesis and secondary tumour formation\u2014remain challenges. Our study introduces an innovative CAR\u2010T engineering approach using mRNA delivered via lipid nanoparticles (LNPs), aiming to reduce costs and enhance safety while maintaining strong anti\u2010tumour efficacy. We developed an LNP\u2010based transfection protocol for efficient delivery of mRNA encoding full\u2010human CAR constructs, achieving high CAR expression and significant cytotoxicity against leukaemic cells in\u00a0vitro. Co\u2010culture with Raji cells showed increased cytokine secretion and tumour cell killing by mRNA\u2010LNP CAR\u2010T cells. Therapeutic efficacy was further demonstrated in an NOD\u2010scid\u2010IL2R\u03b3null (NSG) mouse model with Raji engraftment, where treated mice exhibited marked tumour regression and extended survival. These findings underscore the potential of mRNA\u2010LNPs as a non\u2010viral, effective CAR\u2010T engineering platform, offering a promising alternative to traditional methods that could improve CAR\u2010T safety, efficacy and accessibility in clinical cancer immunotherapy.<\/jats:p>","DOI":"10.1111\/bjh.19988","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T23:39:56Z","timestamp":1736206796000},"page":"628-643","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["<scp>mRNA<\/scp>\u2010laden lipid nanoparticle\u2010enabled humanized <scp>CD19 CAR<\/scp>\u2010T\u2010cell engineering for the eradication of leukaemic cells"],"prefix":"10.1111","volume":"206","author":[{"given":"Zhaozhao","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Ren","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Shu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-4568","authenticated-orcid":false,"given":"Yu","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-2443","authenticated-orcid":false,"given":"Heng","family":"Mei","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan Hubei China"},{"name":"Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease  Wuhan China"},{"name":"Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology  Wuhan China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5551"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30864-7"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29123"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_2_11_9_1","unstructured":"FDA approves first cell\u2010based gene therapy for adult patients with multiple myeloma. Available from:https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approves\u2010first\u2010cell\u2010based\u2010gene\u2010therapy\u2010adult\u2010patients\u2010multiple\u2010myeloma"},{"key":"e_1_2_11_10_1","unstructured":"FDA approves ciltacabtagene autoleucel for relapsed or refractory multiple myeloma. Available from:https:\/\/www.fda.gov\/drugs\/resources\u2010information\u2010approved\u2010drugs\/fda\u2010approves\u2010ciltacabtagene\u2010autoleucel\u2010relapsed\u2010or\u2010refractory\u2010multiple\u2010myeloma"},{"key":"e_1_2_11_11_1","unstructured":"Drug approval document delivery information on August 27 2024. Available from:https:\/\/www.nmpa.gov.cn\/zwfw\/sdxx\/sdxxyp\/yppjfb\/20240827132419122.html"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06243-w"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01126-1"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.08.003"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2107725"},{"key":"e_1_2_11_17_1","first-page":"2256","article-title":"GPIb\u03b1 CAAR T cells function like a trojan horse to eliminate autoreactive B cells to treat immune thrombocytopenia","volume":"109","author":"Zhou J","year":"2024","journal-title":"Haematologica"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226017"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.03.002"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2018.01.025"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0106-0"},{"key":"e_1_2_11_22_1","first-page":"169","article-title":"Lentiviral vectors","volume":"99","author":"Loewen N","year":"2005","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2012.229"},{"key":"e_1_2_11_24_1","unstructured":"2024 safety and availability communications. Available from:https:\/\/www.fda.gov\/vaccines\u2010blood\u2010biologics\/safety\u2010availability\u2010biologics\/2024\u2010safety\u2010and\u2010availability\u2010communications"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2400209"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401530"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00751-6"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2021.06.023"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2020.107534"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c04507"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.124"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201203263"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2008.08.007"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2024.09.019"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713364"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401361"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19590"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-22-0486"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0189"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.03.029"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.03.011"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101139"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2021.03.011"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020097"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/v16040503"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114826"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:16:25Z","timestamp":1747739785000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/bjh.19988"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19988","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"2024-11-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}